查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球代谢组学市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测
市场调查报告书
商品编码
1306545

全球代谢组学市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

Global Metabolomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 221 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球代谢组学市场需求将从2022年的38.9亿美元增长至118.2亿美元，2023-2030年复合年增长率为14.9%。

代谢组学是一个科学研究领域，重点关注生物系统内小分子（称为代谢物）的综合分析和测量。它旨在鉴定和量化生物样本（如血液、尿液、组织或细胞）中的代谢物，并了解它们在不同生物过程中的作用。通过对代谢物的分析，可以深入了解生物体的代谢状态、生化变化和整体生理状况。

市场动态：

质谱和核磁共振光谱等分析技术的进步扩大了代谢组学分析的能力和灵敏度，推动了其在研究和应用领域的需求。向个性化医疗的转变催生了对患者代谢组进行全面分析的需求。这项研究在确定与疾病相关的独特代谢特征、实现早期诊断、患者分层和个性化治疗方法方面发挥着至关重要的作用。对疾病检测、预后和治疗监测所需的准确生物标志物的需求也推动了代谢组学的应用。代谢组学可用于制药和生物技术行业的药物研发。它有助于了解药物代谢、确定药物靶点和评估药物安全性，有助于优化药物开发过程和患者治疗效果。代谢组学应用于农业和食品科学，有助于作物改良、食品质量评估以及了解植物和微生物的新陈代谢。政府倡议、支持性资金和科学界的合作进一步推动了该市场的增长和应用。

研究涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构，评估全球竞争吸引力。此外，这些工具还对全球代谢组学市场的各个细分市场进行了全面评估。代谢组学行业的增长和趋势为本研究提供了整体方法。

区域分析：

该部分涵盖了区域前景，突出了北美、欧洲、亚太、拉美以及中东和非洲地区代谢组学市场的当前和未来需求。此外，该部分还重点分析了所有主要地区各个应用领域的需求、估计和预测。

该研究还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。代谢组学市场的主要参与者包括沃特世公司（美国）、安捷伦科技公司（美国）、岛津公司（日本）、赛默飞世尔科技公司（美国）、丹纳赫公司（美国）、布鲁克公司（美国）、珀金埃尔默公司（美国）、默克公司（德国）、通用电气医疗保健公司（美国）、日立高新技术公司（日本）。人类代谢组技术公司（日本）、LECO公司（美国）。Metabolon, Inc.（美国）、Bio-Rad Laboratories（美国）、Scion Instruments（美国）、DANI Instruments S.p.A.（意大利）、GL Sciences（日本）、SRI Instruments（美国）、Kore Technology Ltd. （英国）、JASCO.(英国)和JASCO公司(美国)(共20家公司)。这部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制服务。

目 录

第一章：前言

  • 说明
    • 目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：代谢组学-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品和服务分类的市场吸引力分析
    • 按生物信息学工具和服务的市场吸引力分析
    • 按应用分类的市场吸引力分析
    • 按适应症分类的市场吸引力分析
    • 按最终用户市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：全球代谢组学市场分析：按产品和服务分类

  • 产品和服务概述
  • 历史和预测数据
  • 按产品和服务分析
  • 代谢组学仪器
  • 分离工具（气相色谱、高效液相色谱、超高效液相色谱、毛细管电泳）
  • 检测工具（核磁共振（NMR）光谱、质谱（MS）、表面质量分析）

第六章：全球代谢组学市场分析：按生物信息学工具和服务分类

  • 生物信息学工具和服务概述
  • 历史和预测数据
  • 生物信息学工具和服务分析
  • 生物信息学服务
  • 生物信息学工具和数据库

第七章 ：全球代谢组学市场分析：按应用分类

  • 应用概述
  • 历史和预测数据
  • 应用分析
  • 生物标志物发现
  • 药物发现
  • 毒理学测试
  • 营养基因组学
  • 功能基因组学
  • 个性化医疗
  • 其他

第八章：全球代谢组学市场分析：按适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按适应症分析
  • 癌症
  • 心血管疾病
  • 神经系统疾病
  • 代谢性疾病
  • 先天性代谢异常
  • 其他疾病

第九章：全球代谢组学市场分析：按终端用户分类

  • 终端用户概述
  • 历史和预测数据
  • 终端用户分析
  • 学术研究机构
  • 制药和生物技术公司
  • 合同研究组织
  • 其他

第10章：全球代谢组学市场分析：按地域划分

  • 地区前景
  • 地区介绍
  • 北美销售分析
    • 概述、历史和预测数据 销售分析
    • 北美地区销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据 销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据 销售分析
    • 亚太地区细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据 销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据 销售分析
    • 中东及非洲地区销售分析
    • 中东及非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东及非洲其他地区销售分析

第十一章 ：代谢组学公司的竞争格局

  • 代谢组学市场竞争
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品发布
  • 其他发展

第十二章 ：公司概况

  • 公司份额分析
  • 市场集中度
  • Waters Corporation (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Agilent Technologies (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Shimadzu Corporation (Japan)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Thermo Fisher Scientific (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Danaher Corporation (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bruker Corporation (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • PerkinElmer (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Merck KGaA (Germany)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GE Healthcare (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Hitachi High- Technologies Corporation (Japan)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Human Metabolome Technologies Inc. (Japan)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • LECO Corporation (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Metabolon Inc. (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bio-Rad Laboratories (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Scion Instruments (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • DANI Instruments S.p.A. (Italy)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GL Sciences (Japan)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • SRI Instruments (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Kore Technology Ltd. (UK)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • JASCO Inc. (US)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

Product Code: VMR112111504

The global demand for Metabolomics Market is presumed to reach the market size of nearly USD 11.82 BN by 2030 from USD 3.89 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Metabolomics is a field of scientific study that focuses on the comprehensive analysis and measurement of small molecules, known as metabolites, within a biological system. It aims to identify and quantify metabolites present in biological samples, such as blood, urine, tissues, or cells, and to understand their roles in different biological processes. The analysis of metabolites provides valuable insights into the metabolic state, biochemical changes, and overall physiological condition of an organism.

MARKET DYNAMICS:

The advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have expanded the capabilities and sensitivity of metabolomics analysis, driving its demand in research and applications. The shift towards personalized medicine has created a demand for comprehensive profiling of patients' metabolomes. The study plays a crucial role in identifying unique metabolic signatures associated with diseases, enabling early diagnosis, stratification of patients, and personalized treatment approaches. The need for accurate biomarkers for disease detection, prognosis, and therapeutic monitoring also fuels the adoption of metabolomics. It is used for drug discovery and development in the pharmaceutical and biotechnology industries. It aids in understanding drug metabolism, identifying drug targets, and assessing drug safety profiles, contributing to optimized drug development processes and patient outcomes. Metabolomics finds applications in agriculture and food science, contributing to crop improvement, food quality assessment, and understanding plant and microbial metabolism. Government initiatives, supportive funding, and collaborations within the scientific community further drive the growth and adoption of this market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metabolomics. The growth and trends of metabolomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the metabolomics market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Metabolomics Instruments
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis)

By Bioinformatics Tools And Services

  • Bioinformatics Services
  • Bioinformatics Tools And Databases

By Appication

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Other

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Inborn Errors Of Metabolism
  • Other

By End User

  • Academic And Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Metabolomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metabolomics market include Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High- Technologies Corporation (Japan). Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US). Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) (Total 20 companies). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . METABOLOMICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Bioinformatics Tools And Services
    • 3.7.3 Market Attractiveness Analysis By Appication
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METABOLOMICS MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1 Overview by Product & Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Service
  • 5.4 Metabolomics Instruments Historic and Forecast Sales by Regions
  • 5.5 Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Historic and Forecast Sales by Regions
  • 5.6 Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Historic and Forecast Sales by Regions

6 . GLOBAL METABOLOMICS MARKET ANALYSIS BY BIOINFORMATICS TOOLS AND SERVICES

  • 6.1 Overview by Bioinformatics Tools And Services
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Bioinformatics Tools And Services
  • 6.4 Bioinformatics Services Historic and Forecast Sales by Regions
  • 6.5 Bioinformatics Tools And Databases Historic and Forecast Sales by Regions

7 . GLOBAL METABOLOMICS MARKET ANALYSIS BY APPICATION

  • 7.1 Overview by Appication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Appication
  • 7.4 Biomarker Discovery Historic and Forecast Sales by Regions
  • 7.5 Drug Discovery Historic and Forecast Sales by Regions
  • 7.6 Toxicology Testing Historic and Forecast Sales by Regions
  • 7.7 Nutrigenomics Historic and Forecast Sales by Regions
  • 7.8 Functional Genomics Historic and Forecast Sales by Regions
  • 7.9 Personalized Medicine Historic and Forecast Sales by Regions
  • 7.10. Other Historic and Forecast Sales by Regions

8 . GLOBAL METABOLOMICS MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Cancer Historic and Forecast Sales by Regions
  • 8.5 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 8.6 Neurological Disorders Historic and Forecast Sales by Regions
  • 8.7 Metabolic Disorders Historic and Forecast Sales by Regions
  • 8.8 Inborn Errors Of Metabolism Historic and Forecast Sales by Regions
  • 8.9 Other Historic and Forecast Sales by Regions

9 . GLOBAL METABOLOMICS MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 9.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.6 Contract Research Organizations Historic and Forecast Sales by Regions
  • 9.7 Other Historic and Forecast Sales by Regions

10 . GLOBAL METABOLOMICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE METABOLOMICS COMPANIES

  • 11.1. Metabolomics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF METABOLOMICS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Waters Corporation (US)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Agilent Technologies (US)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Shimadzu Corporation (Japan)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Thermo Fisher Scientific (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Danaher Corporation (US)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bruker Corporation (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. PerkinElmer (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Merck KGaA (Germany)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. GE Healthcare (US)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Hitachi High- Technologies Corporation (Japan)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Human Metabolome Technologies Inc. (Japan)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. LECO Corporation (US)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Metabolon Inc. (US)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Bio-Rad Laboratories (US)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Scion Instruments (US)
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. DANI Instruments S.p.A. (Italy)
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. GL Sciences (Japan)
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. SRI Instruments (US)
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. Kore Technology Ltd. (UK)
    • 12.21.1. Company Overview
    • 12.21.2. Company Revenue
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. JASCO Inc. (US)
    • 12.22.1. Company Overview
    • 12.22.2. Company Revenue
    • 12.22.3. Products
    • 12.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Analysis Market by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Metabolomics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Metabolomics
  • Market Research Process
  • Market Research Methodology
  • Global Metabolomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Bioinformatics Tools And Services
  • Market Attractiveness Analysis by Appication
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Metabolomics Instruments Market Sales by Geography (USD MN)
  • Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Market Sales by Geography (USD MN)
  • Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Market Sales by Geography (USD MN)
  • Global Market Analysis by Bioinformatics Tools And Services (USD MN)
  • Bioinformatics Services Market Sales by Geography (USD MN)
  • Bioinformatics Tools And Databases Market Sales by Geography (USD MN)
  • Global Market Analysis by Appication (USD MN)
  • Biomarker Discovery Market Sales by Geography (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicology Testing Market Sales by Geography (USD MN)
  • Nutrigenomics Market Sales by Geography (USD MN)
  • Functional Genomics Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Metabolic Disorders Market Sales by Geography (USD MN)
  • Inborn Errors Of Metabolism Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.